Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose.
The purpose of this study was to determine whether the sedentary dog is able to autoregulate glucose production (R(a)) in response to non-insulin-induced changes (<20 mg/dl) in arterial glucose. Dogs had catheters implanted >16 days before study. Protocols consisted of basal (-30 to 0 min) and bilateral renal arterial phloridzin infusion (0-180 min) periods. Somatostatin was infused, and glucagon and insulin were replaced to basal levels. In one protocol (Phl +/- Glc), glucose was allowed to fall from t = 0-90 min. This was followed by a period when glucose was infused to restore euglycemia (90-150 min) and a period when glucose was allowed to fall again (150-180 min). In a second protocol (EC), glucose was infused to compensate for the renal glucose loss due to phloridzin and maintain euglycemia from t = 0-180 min. Arterial insulin, glucagon, cortisol, and catecholamines remained at basal in both protocols. In Phl +/- Glc, glucose fell by approximately 20 mg/dl by t = 90 min with phloridzin infusion. R(a) did not change from basal in Phl +/- Glc despite the fall in glucose for the first 90 min. R(a) was significantly suppressed with restoration of euglycemia from t = 90-150 min (P < 0.05) and returned to basal when glucose was allowed to fall from t = 150-180 min. R(a) did not change from basal in EC. In conclusion, the liver autoregulates R(a) in response to small changes in glucose independently of changes in pancreatic hormones at rest. However, the liver of the resting dog is more sensitive to a small increment, rather than decrement, in arterial glucose.
Camacho
Raul C
RC
Department of Molecular Physiology and Biophysics, and Diabetes Research and Training Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615, USA. Raul.Camacho@vanderbilt.edu
Lacy
D Brooks
DB
James
Freyja D
FD
Coker
Robert H
RH
Wasserman
David H
DH
D000818:Animals; D001158:Arteries; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D004285:Dogs; D005260:Female; D005934:Glucagon / Q000097:blood; D015309:Glucose Clamp Technique; D006706:Homeostasis / Q000502:physiology*; D007328:Insulin / Q000097:blood; D007684:Kidney Tubules / Q000187:drug effects; D008099:Liver / Q000378:metabolism*; D008297:Male; D009004:Monosaccharide Transport Proteins / Q000187:drug effects*; D010695:Phlorhizin / Q000494:pharmacology*; D013004:Somatostatin / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D009004:Monosaccharide Transport Proteins; D013004:Somatostatin; D005934:Glucagon; D010695:Phlorhizin